SCHEMBL26528714

SCHEMBL26528714

C[C@H]1CCn2nc(-c3ccc(CNC(=O)OC(C)(C)C)cc3)nc2C1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.44
▸ LMNA P02545 1/20 0.42
▸ GPR119 Q8TDV5 1/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ROCK2 O75116 1/20 0.40
▸ BRD4 O60885 1/20 0.39
▸ GRM2 Q14416 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HPN P05981 1/20 0.38
▸ ACACB O00763 1/20 0.38
▸ ACACA Q13085 1/20 0.38
▸ ATR Q13535 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26526564 1.00 NAMPT (0.44) NAMPTLMNAGPR119HDAC1L3MBTL1
SCHEMBL26527383 0.90 NAMPT (0.44) NAMPTGPR119HDAC1L3MBTL1ROCK2
SCHEMBL26527978 0.90 NAMPT (0.44) NAMPTGPR119HDAC1L3MBTL1ROCK2
SCHEMBL26527335 0.89 NAMPT (0.45) NAMPTGPR119HDAC1L3MBTL1ROCK2
SCHEMBL26527249 0.88 NAMPT (0.42) NAMPTLMNAGPR119HDAC1L3MBTL1
SCHEMBL26526412 0.87 NAMPT (0.42) NAMPTGPR119HDAC1L3MBTL1ROCK2
SCHEMBL26527148 0.86 NAMPT (0.41) NAMPTLMNAGPR119HDAC1L3MBTL1
SCHEMBL26528233 0.86 NAMPT (0.41) NAMPTLMNAGPR119HDAC1L3MBTL1
SCHEMBL26528084 0.85 NAMPT (0.41) NAMPTGPR119HDAC1L3MBTL1ROCK2
SCHEMBL26527518 0.85 NAMPT (0.45) NAMPTGPR119HDAC1L3MBTL1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023073090-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2023-05-04 — — WO disclosed
Send feedback